NCT04684082

Brief Summary

This is a clinical study with a medical device that bears the CE mark (approval for marketing in the EU) and is applied within its intended use. It is a prospective, single-centre, single-arm, open-label, observational post-market clinical follow-up (PMCF) study using the "Colon Hydromat" system for bowel preparation prior to colonoscopy. The patients will be treated according to the clinical routine and in accordance with the current IFU. Aim of the study is to confirm safety and performance (effectiveness) of colon hydrotherapy as bowel preparation for colonoscopy. Colonic irrigation is regarded as a substitute for standard oral colonic purgative solutions for colonoscopy preparation, especially for patients, who cannot tolerate oral preparations or want to have alternatives because they have experienced the current oral preparations as a burdensome process.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
28

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Feb 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 16, 2020

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 24, 2020

Completed
1 month until next milestone

Study Start

First participant enrolled

February 3, 2021

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 15, 2021

Completed
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2021

Completed
Last Updated

February 8, 2021

Status Verified

December 1, 2020

Enrollment Period

1 month

First QC Date

December 16, 2020

Last Update Submit

February 3, 2021

Conditions

Keywords

Colon HydrotherapyColonoscopy

Outcome Measures

Primary Outcomes (2)

  • Quality of bowel preparation (Colonic Cleanliness), evaluated through the Boston Bowel Preparation Scale (BBPS).

    Quality of bowel preparation validated by numerical scale for bowel cleanse (0-9 best)

    day 1

  • Adverse device events (ADE) and collection of SADE (device or procedure related).

    Assessment of ADE: Patients will be asked in questionnaires, if they had any adverse events, especially nausea, vomiting, pain/cramps, dizziness and headache and rate of patients where colonic irrigation had to be aborted. Assessment of SADE: will be assessed at end of colonoscopy by investigator.

    day 1

Secondary Outcomes (12)

  • BBPS for each segment.

    day 1

  • Patient satisfaction.

    day 1

  • User satisfaction and usability.

    day 1

  • Details to colonic irrigation.

    day 1

  • Details to colonic irrigation.

    day 1

  • +7 more secondary outcomes

Study Arms (1)

Single Group Assignment

Patients will receive colonic irrigation as bowel preparation prior to colonoscopy.

Device: Colonic irrigation with the Colon Hydromat

Interventions

A designated health professional will administer to the patient the colonic irrigation procedure - using the "Colon Hydromat" device, a CE certified device for colonic irrigation and cleansing before endoscopic procedures.

Single Group Assignment

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All patients (men and women) who are planned for a colonoscopy and where anorectal colonic irrigation with the specula can be performed, will be included into the study. The colonic irrigation is regarded as alternative bowel preparation to oral preparations, especially for patients who: * cannot tolerate oral preparations (e.g. cannot drink large volumes, nausea, vomiting), or * want to have alternatives because they have experienced the current oral preparations as a burdensome process, or * had an inadequate colon cleansing following traditional oral preparation, in order to complete the colonoscopy at the same day.

You may qualify if:

  • desire an alternative bowel preparation method to standard of oral polyethylene glycol or other orally taken purgatives, or do not tolerate the oral preparations, or had an inadequate colon cleansing following traditional oral preparation, in order to complete the colonoscopy at the same day.
  • Adult patients (≥ 18 years old) having signed the informed consent.
  • Being able to respond to the self-administered questionnaire.

You may not qualify if:

  • Psychiatric conditions and inability to provide informed consent
  • Emergency colonoscopy
  • Off-label use (application is not within the IFU)
  • Pregnancy and lactation period
  • The patient has one of the contraindications listed in the IFU.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Internistische Gemeinschaftspraxis für Verdauungs- und Stoffwechselerkrankungen

Leipzig, 04105, Germany

RECRUITING

Study Officials

  • Niels Teich, Prof. Dr. med.

    Study centre Leipzig - Internistic Joint Practice

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jochen Huebner

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 16, 2020

First Posted

December 24, 2020

Study Start

February 3, 2021

Primary Completion

March 15, 2021

Study Completion

March 30, 2021

Last Updated

February 8, 2021

Record last verified: 2020-12

Locations